chr2-47386560-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002354.3(EPCAM):​c.904-12T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0389 in 1,591,436 control chromosomes in the GnomAD database, including 1,405 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 124 hom., cov: 33)
Exomes 𝑓: 0.039 ( 1281 hom. )

Consequence

EPCAM
NM_002354.3 intron

Scores

2
Splicing: ADA: 0.00009840
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.60

Publications

3 publications found
Variant links:
Genes affected
EPCAM (HGNC:11529): (epithelial cell adhesion molecule) This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]
EPCAM Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Lynch syndrome 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital diarrhea 5 with tufting enteropathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P, Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-47386560-T-C is Benign according to our data. Variant chr2-47386560-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 258645.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0584 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPCAMNM_002354.3 linkc.904-12T>C intron_variant Intron 8 of 8 ENST00000263735.9 NP_002345.2 P16422

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPCAMENST00000263735.9 linkc.904-12T>C intron_variant Intron 8 of 8 1 NM_002354.3 ENSP00000263735.4 P16422
EPCAMENST00000405271.5 linkc.988-12T>C intron_variant Intron 9 of 9 5 ENSP00000385476.1 B5MCA4
EPCAMENST00000456133.5 linkn.988-12T>C intron_variant Intron 9 of 10 5 ENSP00000410675.1 B5MCA4

Frequencies

GnomAD3 genomes
AF:
0.0343
AC:
5221
AN:
152190
Hom.:
123
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00825
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.0617
Gnomad ASJ
AF:
0.0378
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0566
Gnomad FIN
AF:
0.0458
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0430
Gnomad OTH
AF:
0.0363
GnomAD2 exomes
AF:
0.0402
AC:
9992
AN:
248810
AF XY:
0.0411
show subpopulations
Gnomad AFR exome
AF:
0.00627
Gnomad AMR exome
AF:
0.0561
Gnomad ASJ exome
AF:
0.0419
Gnomad EAS exome
AF:
0.000437
Gnomad FIN exome
AF:
0.0467
Gnomad NFE exome
AF:
0.0391
Gnomad OTH exome
AF:
0.0392
GnomAD4 exome
AF:
0.0394
AC:
56676
AN:
1439128
Hom.:
1281
Cov.:
27
AF XY:
0.0403
AC XY:
28826
AN XY:
716108
show subpopulations
African (AFR)
AF:
0.00530
AC:
176
AN:
33192
American (AMR)
AF:
0.0548
AC:
2422
AN:
44182
Ashkenazi Jewish (ASJ)
AF:
0.0399
AC:
1030
AN:
25840
East Asian (EAS)
AF:
0.000228
AC:
9
AN:
39488
South Asian (SAS)
AF:
0.0648
AC:
5361
AN:
82742
European-Finnish (FIN)
AF:
0.0445
AC:
2355
AN:
52962
Middle Eastern (MID)
AF:
0.0387
AC:
213
AN:
5508
European-Non Finnish (NFE)
AF:
0.0391
AC:
42866
AN:
1095638
Other (OTH)
AF:
0.0377
AC:
2244
AN:
59576
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
2174
4348
6522
8696
10870
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1588
3176
4764
6352
7940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0343
AC:
5222
AN:
152308
Hom.:
124
Cov.:
33
AF XY:
0.0361
AC XY:
2686
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00823
AC:
342
AN:
41568
American (AMR)
AF:
0.0616
AC:
942
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0378
AC:
131
AN:
3468
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5192
South Asian (SAS)
AF:
0.0570
AC:
275
AN:
4822
European-Finnish (FIN)
AF:
0.0458
AC:
486
AN:
10620
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0430
AC:
2927
AN:
68036
Other (OTH)
AF:
0.0360
AC:
76
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
260
521
781
1042
1302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0398
Hom.:
53
Bravo
AF:
0.0318
Asia WGS
AF:
0.0220
AC:
78
AN:
3472

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lynch syndrome 8 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
2.6
DANN
Benign
0.81
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000098
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62139669; hg19: chr2-47613699; COSMIC: COSV107227826; COSMIC: COSV107227826; API